Yayın:
New naphthalene-linked pyrazoline-thiazole hybrids as prominent antilung and antibreast cancer inhibitors

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHALİLİBRAHİM ÇİFTÇİ
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorBelgin Sever
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0003-4847-9711
dc.date.accessioned2026-05-20T09:37:22Z
dc.date.issued2024-12-19
dc.identifier.doi10.55730/1300-0527.3704
dc.identifier.endpage866
dc.identifier.issn1300-0527
dc.identifier.issue6
dc.identifier.openalexW4405804652
dc.identifier.startpage856
dc.identifier.urihttps://hdl.handle.net/11421/38463
dc.identifier.urihttps://doi.org/10.55730/1300-0527.3704
dc.identifier.volume48
dc.language.isoen
dc.relation.ispartofTURKISH JOURNAL OF CHEMISTRY
dc.rightsopenAccess
dc.subjectLapatinib
dc.subjectChemistry
dc.subjectCancer research
dc.subjectPharmacology
dc.subjectIC50
dc.subjectApoptosis
dc.subjectLung cancer
dc.subjectA549 cell
dc.subjectCancer
dc.subjectMTT assay
dc.subjectTyrosine kinase
dc.subjectEpidermal growth factor receptor
dc.subjectBreast cancer
dc.subjectReceptor
dc.subjectOncology
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectTrastuzumab
dc.subject.sdg3
dc.titleNew naphthalene-linked pyrazoline-thiazole hybrids as prominent antilung and antibreast cancer inhibitors
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications